| Intervention With an Erythropoietin-Derived Peptide Protects Against Neuroglial and Vascular Degeneration During Diabetic Retinopathy. | |
| | |
MedLine Citation:
|
PMID: 21911748 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OBJECTIVEErythropoietin (EPO) may be protective for early stage diabetic retinopathy, although there are concerns that it could exacerbate retinal angiogenesis and thrombosis. A peptide based on the EPO helix-B domain (helix B-surface peptide [pHBSP]) is nonerythrogenic but retains tissue-protective properties, and this study evaluates its therapeutic potential in diabetic retinopathy.RESEARCH DESIGN AND METHODSAfter 6 months of streptozotocin-induced diabetes, rats (n = 12) and age-matched nondiabetic controls (n = 12) were evenly split into pHBSP and scrambled peptide groups and injected daily (10 μg/kg per day) for 1 month. The retina was investigated for glial dysfunction, microglial activation, and neuronal DNA damage. The vasculature was dual stained with isolectin and collagen IV. Retinal cytokine expression was quantified using real-time RT-PCR. In parallel, oxygen-induced retinopathy (OIR) was used to evaluate the effects of pHBSP on retinal ischemia and neovascularization (1-30 μg/kg pHBSP or control peptide).RESULTSpHBSP or scrambled peptide treatment did not alter hematocrit. In the diabetic retina, Müller glial expression of glial fibrillary acidic protein was increased when compared with nondiabetic controls, but pHBSP significantly reduced this stress-related response (P < 0.001). CD11b+ microglia and proinflammatory cytokines were elevated in diabetic retina responses, and some of these responses were attenuated by pHBSP (P < 0.01-0.001). pHBSP significantly reduced diabetes-linked DNA damage as determined by 8-hydroxydeoxyguanosine and transferase-mediated dUTP nick-end labeling positivity and also prevented acellular capillary formation (P < 0.05). In OIR, pHBSP had no effect on preretinal neovascularization at any dose.CONCLUSIONSTreatment with an EPO-derived peptide after diabetes is fully established can significantly protect against neuroglial and vascular degenerative pathology without altering hematocrit or exacerbating neovascularization. These findings have therapeutic implications for disorders such as diabetic retinopathy. |
| | |
Authors:
|
Carmel M McVicar; Ross Hamilton; Liza M Colhoun; Tom A Gardiner; Michael Brines; Anthony Cerami; Alan W Stitt |
Related Documents
:
|
1688068 - Hla-dqa1 and dqb1 alleles in french and algerian type 1 diabetic subjects. 3969598 - Hla antigens and non-insulin-dependent diabetes mellitus in young south african indians. 7024028 - Age-related association of insulin-dependent diabetes mellitus with bff1 and the hla-b1... 12941548 - Hla haplotype is associated with diabetes among atomic bomb survivors. 11795898 - R-alpha-lipoic acid action on cell redox status, the insulin receptor, and glucose upta... 21525158 - Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-9-12 |
Journal Detail:
|
Title: Diabetes Volume: - ISSN: 1939-327X ISO Abbreviation: - Publication Date: 2011 Sep |
Date Detail:
|
Created Date: 2011-9-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372763 Medline TA: Diabetes Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Centre for Vision and Vascular Science, Queen's University Belfast, Belfast, Northern Ireland, U.K. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance.
Next Document: CPVL/CHN2 Genetic Variant Is Associated With Diabetic Retinopathy in Chinese Type 2 Diabetic Patient...